Heterodimeric complex of RAR and RXR nuclear receptor ligand-binding domains: Purification, crystallization, and preliminary X-ray diffraction analysis

Protein Expression and Purification

Volumn 19, Issue 2, 2000, Pages 284-288

  Bourguet, William ^a   Andry, Virginie ^a   Iltis, Carole ^a   Klaholz, Bruno ^a   Potier, Noëlle ^b   Van Dorsselaer, Alain ^b   Chambon, Pierre ^a   Gronemeyer, Hinrich ^a   Moras, Dino ^a  

^a Centre de Recherche Interdisciplinaire en Biologie   (France)

^b UNIVERSITÉ DE STRASBOURG   (France)

Author keywords

[No Author keywords available]

Indexed keywords

BINDING SITE; CRYSTAL STRUCTURE; CRYSTALLIZATION; GENE OVEREXPRESSION; LIGAND BINDING; MACROGOL; PROTEIN DOMAIN; RETINOIC ACID RECEPTOR ALPHA; RETINOID X RECEPTOR ALPHA; X RAY DIFFRACTION ANALYSIS;

ESCHERICHIA COLI;

EID: 0033923621     PISSN: 10465928     EISSN: None     Source Type: Journal    
DOI: 10.1006/prep.2000.1248     Document Type: Article

References (17)

1. Chambon P. A decade of molecular biology of retinoic acid receptors. FASEB J. 10:1996;940-954.
2. Wurtz J. M., Bourguet W., Renaud J. P., Vivat V., Chambon P., Moras D., Gronemeyer H. A canonical structure for the ligand-binding domain of nuclear receptors. Nat. Struct. Biol. 3:1996;87-94.
3. Moras D., Gronemeyer H. The nuclear receptor ligand-binding domain: Structure and function. Curr. Opin. Cell Biol. 10:1998;384-391.
4. Torchia J., Glass C., Rosenfeld M. G. Co-activators and co-repressors in the integration of transcriptional response. Curr. Opin. Cell Biol. 10:1998;373-383.
5. Freedman L. P. Increasing the complexity of coactivation in nuclear receptor signaling. Cell. 97:1999;5-8.
6. Gehin M., Vivat V., Wurtz J. M., Losson R., Chambon P., Moras D., Gronemeyer H. Structural basis for engineering of retinoic acid receptor isotype-selective agonists and antagonists. Chem. Biol. 6:1999;519-529.
7. Vivat V., Zechel C., Wurtz J. M., Bourguet W., Kagechika H., Umemiya H., Shudo K., Moras D., Gronemeyer H., Chambon P. A mutation mimicking ligand-induced conformational change yields a constitutive RXR that senses allosteric effects in heterodimers. EMBO J. 16:1997;5697-5709.
8. Petkovich M., Brand N. J., Krust A., Chambon P. A human retinoic acid receptor which belongs to the family of nuclear receptors. Nature. 330:1987;444-450.
9. Giguere V., Ong E. S., Segui P., Evans R. M. Identification of a receptor for the morphogen retinoic acid. Nature. 330:1987;624-629.
10. Leid M., Kastner P., Lyons R., Nakshatri H., Saunders M., Zacharewski T., Chen J-Y., Staub A., Garnier J. M., Mader S., Chambon P. Purification, cloning and RXR identity of the HeLa cell factor with which RAR or TR heterodimerizes to bind target sequences efficiently. Cell. 68:1992;377-395.
11. Otwinowski Z., Minor W. Processing of X-ray diffraction data collected in oscillation mode. Methods Enzymol. 276:1997;307-326.
12. Navaza J. AMoRe: An automated package for molecular replacement. Acta Cryst. A50:1994;157-163.
13. Renaud J.-P., Rochel N., Ruff M., Vivat V., Chambon P., Gronemeyer H., Moras D. Crystal structure of the RAR-γ ligand-binding domain bound to all-trans retinoic acid. Nature. 378:1995;681-689.
14. Mann M., Wilm M. Electrospray mass spectrometry for protein characterization. Trends Biochem. Sci. 20:1995;219-224.
15. Fenn J. B., Mann M., Meng C. K., Wong S. F., Whitehouse C. M. Electrospray ionization for mass spectrometry of large biomolecules. Science. 246:1989;64-71.
16. Loo J. A. Studying noncovalent protein complexes by electrospray ionization mass spectrometry. Mass Spectrom. Rev. 16:1997;1-23.
17. Tanenbaum D. M., Wang Y., Williams S. P., Sigler P. B. Crystallographic comparison of the estrogen and progesterone receptor's ligand binding domains. Proc. Natl. Acad. Sci. USA. 95:1998;5998-6003.